← SynDRA
QUEMLICLUSTAT
SynDRA canonical compound SYN0039893 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | NT5E |
| Mechanism of action | cd antagonist |
| Indication | pancreatic cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- cd antagonist
- NT5E INHIBITOR
Drug classes
- Immune Checkpoint Inhibitors
Cross-references
Synonyms
- AB680
- AB-680
- COMPOUND 55
- UNII-J6K8WSV73A
- J6K8WSV73A
- CHEMBL4471306
- (((((2R,3S,4R,5R)-5-(6-chloro-4-(((S)-1-(2-fluorophenyl)ethyl)amino)-1H-pyrazolo[3,4-b]pyridin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid
- [[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-[[(1~{S})-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid
- SCHEMBL19100484
- GTPL10707
- BDBM50527134
- HY-125286
- CS-0090231
- [[(2R,3S,4R,5R)-5-[6-chloro-4-[[(1S)-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid
- QDH
- AB 680
- RefChem:178058
- CD73 Inhibitor AB680
- Quemliclustat [USAN]
- WHO 11621
- Quemliclustat [WHO-DD]
- QUEMLICLUSTAT [INN]
- CD73 inhibitor AB-680
- orb1310029
- SCHEMBL30373898
- GLXC-22667
- EX-A4998
- AKOS040732358
- EBC-415134
- AC-36768
- BA178946
- F78354
- T10216
- A040068
Look up QUEMLICLUSTAT in the interactive SynDRA portal →